sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Global Alpha-1 Antitrypsin Drugs Market Insights and Forecast to 2026

Global Alpha-1 Antitrypsin Drugs Market Insights and Forecast to 2026

Category : Pharmaceuticals and Healthcare QY Research Pages :110
Published Date : 2020-12-02

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the Alpha-1 Antitrypsin Drugs Market with our analysts monitoring the situation across the globe.
Alpha-1 Antitrypsin Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alpha-1 Antitrypsin Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Alpha-1 Antitrypsin Drugs market is segmented into Parenteral Inhalation Segment by Application, the Alpha-1 Antitrypsin Drugs market is segmented into Drugstore Hospital Others Regional and Country-level Analysis The Alpha-1 Antitrypsin Drugs market is analysed and market size information is provided by regions (countries). The key regions covered in the Alpha-1 Antitrypsin Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026. Competitive Landscape and Alpha-1 Antitrypsin Drugs Market Share Analysis Alpha-1 Antitrypsin Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Alpha-1 Antitrypsin Drugs business, the date to enter into the Alpha-1 Antitrypsin Drugs market, Alpha-1 Antitrypsin Drugs product introduction, recent developments, etc. The major vendors covered: Baxter CSL Behring Grifols Kamada Abeona Therapeutics Alnylam Pharmaceuticals Applied Genetic Technologies Corp Arrowhead Research Corporation Baxalta
1 Study Coverage 1.1 Alpha-1 Antitrypsin Drugs Product Introduction 1.2 Market Segments 1.3 Key Alpha-1 Antitrypsin Drugs Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Type 1.4.2 Parenteral 1.4.3 Inhalation 1.5 Market by Application 1.5.1 Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Application 1.5.2 Drugstore 1.5.3 Hospital 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Alpha-1 Antitrypsin Drugs Market Size, Estimates and Forecasts 2.1.1 Global Alpha-1 Antitrypsin Drugs Revenue 2015-2026 2.1.2 Global Alpha-1 Antitrypsin Drugs Sales 2015-2026 2.2 Global Alpha-1 Antitrypsin Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.2.1 Global Alpha-1 Antitrypsin Drugs Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Alpha-1 Antitrypsin Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Alpha-1 Antitrypsin Drugs Competitor Landscape by Players 3.1 Alpha-1 Antitrypsin Drugs Sales by Manufacturers 3.1.1 Alpha-1 Antitrypsin Drugs Sales by Manufacturers (2015-2020) 3.1.2 Alpha-1 Antitrypsin Drugs Sales Market Share by Manufacturers (2015-2020) 3.2 Alpha-1 Antitrypsin Drugs Revenue by Manufacturers 3.2.1 Alpha-1 Antitrypsin Drugs Revenue by Manufacturers (2015-2020) 3.2.2 Alpha-1 Antitrypsin Drugs Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Alpha-1 Antitrypsin Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Alpha-1 Antitrypsin Drugs Revenue in 2019 3.2.5 Global Alpha-1 Antitrypsin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Alpha-1 Antitrypsin Drugs Price by Manufacturers 3.4 Alpha-1 Antitrypsin Drugs Manufacturing Base Distribution, Product Types 3.4.1 Alpha-1 Antitrypsin Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Alpha-1 Antitrypsin Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Alpha-1 Antitrypsin Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Alpha-1 Antitrypsin Drugs Market Size by Type (2015-2020) 4.1.1 Global Alpha-1 Antitrypsin Drugs Sales by Type (2015-2020) 4.1.2 Global Alpha-1 Antitrypsin Drugs Revenue by Type (2015-2020) 4.1.3 Alpha-1 Antitrypsin Drugs Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Alpha-1 Antitrypsin Drugs Market Size Forecast by Type (2021-2026) 4.2.1 Global Alpha-1 Antitrypsin Drugs Sales Forecast by Type (2021-2026) 4.2.2 Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Type (2021-2026) 4.2.3 Alpha-1 Antitrypsin Drugs Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Alpha-1 Antitrypsin Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026) 5.1 Global Alpha-1 Antitrypsin Drugs Market Size by Application (2015-2020) 5.1.1 Global Alpha-1 Antitrypsin Drugs Sales by Application (2015-2020) 5.1.2 Global Alpha-1 Antitrypsin Drugs Revenue by Application (2015-2020) 5.1.3 Alpha-1 Antitrypsin Drugs Price by Application (2015-2020) 5.2 Alpha-1 Antitrypsin Drugs Market Size Forecast by Application (2021-2026) 5.2.1 Global Alpha-1 Antitrypsin Drugs Sales Forecast by Application (2021-2026) 5.2.2 Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Application (2021-2026) 5.2.3 Global Alpha-1 Antitrypsin Drugs Price Forecast by Application (2021-2026) 6 North America 6.1 North America Alpha-1 Antitrypsin Drugs by Country 6.1.1 North America Alpha-1 Antitrypsin Drugs Sales by Country 6.1.2 North America Alpha-1 Antitrypsin Drugs Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Alpha-1 Antitrypsin Drugs Market Facts & Figures by Type 6.3 North America Alpha-1 Antitrypsin Drugs Market Facts & Figures by Application 7 Europe 7.1 Europe Alpha-1 Antitrypsin Drugs by Country 7.1.1 Europe Alpha-1 Antitrypsin Drugs Sales by Country 7.1.2 Europe Alpha-1 Antitrypsin Drugs Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Alpha-1 Antitrypsin Drugs Market Facts & Figures by Type 7.3 Europe Alpha-1 Antitrypsin Drugs Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Alpha-1 Antitrypsin Drugs by Region 8.1.1 Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Region 8.1.2 Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Alpha-1 Antitrypsin Drugs Market Facts & Figures by Type 8.3 Asia Pacific Alpha-1 Antitrypsin Drugs Market Facts & Figures by Application 9 Latin America 9.1 Latin America Alpha-1 Antitrypsin Drugs by Country 9.1.1 Latin America Alpha-1 Antitrypsin Drugs Sales by Country 9.1.2 Latin America Alpha-1 Antitrypsin Drugs Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Alpha-1 Antitrypsin Drugs Market Facts & Figures by Type 9.3 Central & South America Alpha-1 Antitrypsin Drugs Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Alpha-1 Antitrypsin Drugs by Country 10.1.1 Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Country 10.1.2 Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Facts & Figures by Type 10.3 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Facts & Figures by Application 11 Company Profiles 11.1 Baxter 11.1.1 Baxter Corporation Information 11.1.2 Baxter Description and Business Overview 11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Baxter Alpha-1 Antitrypsin Drugs Products Offered 11.1.5 Baxter Related Developments 11.2 CSL Behring 11.2.1 CSL Behring Corporation Information 11.2.2 CSL Behring Description and Business Overview 11.2.3 CSL Behring Sales, Revenue and Gross Margin (2015-2020) 11.2.4 CSL Behring Alpha-1 Antitrypsin Drugs Products Offered 11.2.5 CSL Behring Related Developments 11.3 Grifols 11.3.1 Grifols Corporation Information 11.3.2 Grifols Description and Business Overview 11.3.3 Grifols Sales, Revenue and Gross Margin (2015-2020) 11.3.4 Grifols Alpha-1 Antitrypsin Drugs Products Offered 11.3.5 Grifols Related Developments 11.4 Kamada 11.4.1 Kamada Corporation Information 11.4.2 Kamada Description and Business Overview 11.4.3 Kamada Sales, Revenue and Gross Margin (2015-2020) 11.4.4 Kamada Alpha-1 Antitrypsin Drugs Products Offered 11.4.5 Kamada Related Developments 11.5 Abeona Therapeutics 11.5.1 Abeona Therapeutics Corporation Information 11.5.2 Abeona Therapeutics Description and Business Overview 11.5.3 Abeona Therapeutics Sales, Revenue and Gross Margin (2015-2020) 11.5.4 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Products Offered 11.5.5 Abeona Therapeutics Related Developments 11.6 Alnylam Pharmaceuticals 11.6.1 Alnylam Pharmaceuticals Corporation Information 11.6.2 Alnylam Pharmaceuticals Description and Business Overview 11.6.3 Alnylam Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 11.6.4 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Products Offered 11.6.5 Alnylam Pharmaceuticals Related Developments 11.7 Applied Genetic Technologies Corp 11.7.1 Applied Genetic Technologies Corp Corporation Information 11.7.2 Applied Genetic Technologies Corp Description and Business Overview 11.7.3 Applied Genetic Technologies Corp Sales, Revenue and Gross Margin (2015-2020) 11.7.4 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Products Offered 11.7.5 Applied Genetic Technologies Corp Related Developments 11.8 Arrowhead Research Corporation 11.8.1 Arrowhead Research Corporation Corporation Information 11.8.2 Arrowhead Research Corporation Description and Business Overview 11.8.3 Arrowhead Research Corporation Sales, Revenue and Gross Margin (2015-2020) 11.8.4 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Products Offered 11.8.5 Arrowhead Research Corporation Related Developments 11.9 Baxalta 11.9.1 Baxalta Corporation Information 11.9.2 Baxalta Description and Business Overview 11.9.3 Baxalta Sales, Revenue and Gross Margin (2015-2020) 11.9.4 Baxalta Alpha-1 Antitrypsin Drugs Products Offered 11.9.5 Baxalta Related Developments 11.1 Baxter 11.1.1 Baxter Corporation Information 11.1.2 Baxter Description and Business Overview 11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Baxter Alpha-1 Antitrypsin Drugs Products Offered 11.1.5 Baxter Related Developments 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Alpha-1 Antitrypsin Drugs Market Estimates and Projections by Region 12.1.1 Global Alpha-1 Antitrypsin Drugs Sales Forecast by Regions 2021-2026 12.1.2 Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Regions 2021-2026 12.2 North America Alpha-1 Antitrypsin Drugs Market Size Forecast (2021-2026) 12.2.1 North America: Alpha-1 Antitrypsin Drugs Sales Forecast (2021-2026) 12.2.2 North America: Alpha-1 Antitrypsin Drugs Revenue Forecast (2021-2026) 12.2.3 North America: Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2021-2026) 12.3 Europe Alpha-1 Antitrypsin Drugs Market Size Forecast (2021-2026) 12.3.1 Europe: Alpha-1 Antitrypsin Drugs Sales Forecast (2021-2026) 12.3.2 Europe: Alpha-1 Antitrypsin Drugs Revenue Forecast (2021-2026) 12.3.3 Europe: Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Alpha-1 Antitrypsin Drugs Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Alpha-1 Antitrypsin Drugs Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Alpha-1 Antitrypsin Drugs Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Alpha-1 Antitrypsin Drugs Market Size Forecast by Region (2021-2026) 12.5 Latin America Alpha-1 Antitrypsin Drugs Market Size Forecast (2021-2026) 12.5.1 Latin America: Alpha-1 Antitrypsin Drugs Sales Forecast (2021-2026) 12.5.2 Latin America: Alpha-1 Antitrypsin Drugs Revenue Forecast (2021-2026) 12.5.3 Latin America: Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Alpha-1 Antitrypsin Drugs Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Alpha-1 Antitrypsin Drugs Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter's Five Forces Analysis 13.5 Primary Interviews with Key Alpha-1 Antitrypsin Drugs Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Alpha-1 Antitrypsin Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

Get Free Sample

List of Tables Table 1. Alpha-1 Antitrypsin Drugs Market Segments Table 2. Ranking of Global Top Alpha-1 Antitrypsin Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of Parenteral Table 5. Major Manufacturers of Inhalation Table 6. Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Application 2020-2026 (K Units) Table 7. Global Alpha-1 Antitrypsin Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 8. Global Alpha-1 Antitrypsin Drugs Sales by Regions 2015-2020 (K Units) Table 9. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Regions (2015-2020) Table 10. Global Alpha-1 Antitrypsin Drugs Revenue by Regions 2015-2020 (US$ Million) Table 11. Global Alpha-1 Antitrypsin Drugs Sales by Manufacturers (2015-2020) (K Units) Table 12. Global Alpha-1 Antitrypsin Drugs Sales Share by Manufacturers (2015-2020) Table 13. Global Alpha-1 Antitrypsin Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 14. Global Alpha-1 Antitrypsin Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alpha-1 Antitrypsin Drugs as of 2019) Table 15. Alpha-1 Antitrypsin Drugs Revenue by Manufacturers (2015-2020) (US$ Million) Table 16. Alpha-1 Antitrypsin Drugs Revenue Share by Manufacturers (2015-2020) Table 17. Key Manufacturers Alpha-1 Antitrypsin Drugs Price (2015-2020) (USD/Unit) Table 18. Alpha-1 Antitrypsin Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table 19. Manufacturers Alpha-1 Antitrypsin Drugs Product Type Table 20. Date of International Manufacturers Enter into Alpha-1 Antitrypsin Drugs Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Global Alpha-1 Antitrypsin Drugs Sales by Type (2015-2020) (K Units) Table 23. Global Alpha-1 Antitrypsin Drugs Sales Share by Type (2015-2020) Table 24. Global Alpha-1 Antitrypsin Drugs Revenue by Type (2015-2020) (US$ Million) Table 25. Global Alpha-1 Antitrypsin Drugs Revenue Share by Type (2015-2020) Table 26. Alpha-1 Antitrypsin Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit) Table 27. Global Alpha-1 Antitrypsin Drugs Sales by Application (2015-2020) (K Units) Table 28. Global Alpha-1 Antitrypsin Drugs Sales Share by Application (2015-2020) Table 29. North America Alpha-1 Antitrypsin Drugs Sales by Country (2015-2020) (K Units) Table 30. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2015-2020) Table 31. North America Alpha-1 Antitrypsin Drugs Revenue by Country (2015-2020) (US$ Million) Table 32. North America Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2015-2020) Table 33. North America Alpha-1 Antitrypsin Drugs Sales by Type (2015-2020) (K Units) Table 34. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2015-2020) Table 35. North America Alpha-1 Antitrypsin Drugs Sales by Application (2015-2020) (K Units) Table 36. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2015-2020) Table 37. Europe Alpha-1 Antitrypsin Drugs Sales by Country (2015-2020) (K Units) Table 38. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2015-2020) Table 39. Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2015-2020) (US$ Million) Table 40. Europe Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2015-2020) Table 41. Europe Alpha-1 Antitrypsin Drugs Sales by Type (2015-2020) (K Units) Table 42. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2015-2020) Table 43. Europe Alpha-1 Antitrypsin Drugs Sales by Application (2015-2020) (K Units) Table 44. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2015-2020) Table 45. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Region (2015-2020) (K Units) Table 46. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2015-2020) Table 47. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Region (2015-2020) (US$ Million) Table 48. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2015-2020) Table 49. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Type (2015-2020) (K Units) Table 50. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2015-2020) Table 51. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Application (2015-2020) (K Units) Table 52. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2015-2020) Table 53. Latin America Alpha-1 Antitrypsin Drugs Sales by Country (2015-2020) (K Units) Table 54. Latin America Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2015-2020) Table 55. Latin Americaa Alpha-1 Antitrypsin Drugs Revenue by Country (2015-2020) (US$ Million) Table 56. Latin America Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2015-2020) Table 57. Latin America Alpha-1 Antitrypsin Drugs Sales by Type (2015-2020) (K Units) Table 58. Latin America Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2015-2020) Table 59. Latin America Alpha-1 Antitrypsin Drugs Sales by Application (2015-2020) (K Units) Table 60. Latin America Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2015-2020) Table 61. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Country (2015-2020) (K Units) Table 62. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2015-2020) Table 63. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2015-2020) (US$ Million) Table 64. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2015-2020) Table 65. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Type (2015-2020) (K Units) Table 66. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2015-2020) Table 67. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Application (2015-2020) (K Units) Table 68. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2015-2020) Table 69. Baxter Corporation Information Table 70. Baxter Description and Major Businesses Table 71. Baxter Alpha-1 Antitrypsin Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 72. Baxter Product Table 73. Baxter Recent Development Table 74. CSL Behring Corporation Information Table 75. CSL Behring Description and Major Businesses Table 76. CSL Behring Alpha-1 Antitrypsin Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 77. CSL Behring Product Table 78. CSL Behring Recent Development Table 79. Grifols Corporation Information Table 80. Grifols Description and Major Businesses Table 81. Grifols Alpha-1 Antitrypsin Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 82. Grifols Product Table 83. Grifols Recent Development Table 84. Kamada Corporation Information Table 85. Kamada Description and Major Businesses Table 86. Kamada Alpha-1 Antitrypsin Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 87. Kamada Product Table 88. Kamada Recent Development Table 89. Abeona Therapeutics Corporation Information Table 90. Abeona Therapeutics Description and Major Businesses Table 91. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 92. Abeona Therapeutics Product Table 93. Abeona Therapeutics Recent Development Table 94. Alnylam Pharmaceuticals Corporation Information Table 95. Alnylam Pharmaceuticals Description and Major Businesses Table 96. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 97. Alnylam Pharmaceuticals Product Table 98. Alnylam Pharmaceuticals Recent Development Table 99. Applied Genetic Technologies Corp Corporation Information Table 100. Applied Genetic Technologies Corp Description and Major Businesses Table 101. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 102. Applied Genetic Technologies Corp Product Table 103. Applied Genetic Technologies Corp Recent Development Table 104. Arrowhead Research Corporation Corporation Information Table 105. Arrowhead Research Corporation Description and Major Businesses Table 106. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 107. Arrowhead Research Corporation Product Table 108. Arrowhead Research Corporation Recent Development Table 109. Baxalta Corporation Information Table 110. Baxalta Description and Major Businesses Table 111. Baxalta Alpha-1 Antitrypsin Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 112. Baxalta Product Table 113. Baxalta Recent Development Table 114. Global Alpha-1 Antitrypsin Drugs Sales Forecast by Regions (2021-2026) (K Units) Table 115. Global Alpha-1 Antitrypsin Drugs Sales Market Share Forecast by Regions (2021-2026) Table 116. Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Regions (2021-2026) (US$ Million) Table 117. Global Alpha-1 Antitrypsin Drugs Revenue Market Share Forecast by Regions (2021-2026) Table 118. North America: Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2021-2026) (K Units) Table 119. North America: Alpha-1 Antitrypsin Drugs Revenue Forecast by Country (2021-2026) (US$ Million) Table 120. Europe: Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2021-2026) (K Units) Table 121. Europe: Alpha-1 Antitrypsin Drugs Revenue Forecast by Country (2021-2026) (US$ Million) Table 122. Asia Pacific: Alpha-1 Antitrypsin Drugs Sales Forecast by Region (2021-2026) (K Units) Table 123. Asia Pacific: Alpha-1 Antitrypsin Drugs Revenue Forecast by Region (2021-2026) (US$ Million) Table 124. Latin America: Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2021-2026) (K Units) Table 125. Latin America: Alpha-1 Antitrypsin Drugs Revenue Forecast by Country (2021-2026) (US$ Million) Table 126. Middle East and Africa: Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2021-2026) (K Units) Table 127. Middle East and Africa: Alpha-1 Antitrypsin Drugs Revenue Forecast by Country (2021-2026) (US$ Million) Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 129. Key Challenges Table 130. Market Risks Table 131. Main Points Interviewed from Key Alpha-1 Antitrypsin Drugs Players Table 132. Alpha-1 Antitrypsin Drugs Customers List Table 133. Alpha-1 Antitrypsin Drugs Distributors List Table 134. Research Programs/Design for This Report Table 135. Key Data Information from Secondary Sources Table 136. Key Data Information from Primary Sources List of Figures Figure 1. Alpha-1 Antitrypsin Drugs Product Picture Figure 2. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type in 2020 & 2026 Figure 3. Parenteral Product Picture Figure 4. Inhalation Product Picture Figure 5. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application in 2020 & 2026 Figure 6. Drugstore Figure 7. Hospital Figure 8. Others Figure 9. Alpha-1 Antitrypsin Drugs Report Years Considered Figure 10. Global Alpha-1 Antitrypsin Drugs Market Size 2015-2026 (US$ Million) Figure 11. Global Alpha-1 Antitrypsin Drugs Sales 2015-2026 (K Units) Figure 12. Global Alpha-1 Antitrypsin Drugs Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2015-2020) Figure 14. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region in 2019 Figure 15. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2015-2020) Figure 16. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region in 2019 Figure 17. Global Alpha-1 Antitrypsin Drugs Sales Share by Manufacturer in 2019 Figure 18. The Top 10 and 5 Players Market Share by Alpha-1 Antitrypsin Drugs Revenue in 2019 Figure 19. Alpha-1 Antitrypsin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 20. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2015-2020) Figure 21. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type in 2019 Figure 22. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2015-2020) Figure 23. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type in 2019 Figure 24. Global Alpha-1 Antitrypsin Drugs Market Share by Price Range (2015-2020) Figure 25. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2015-2020) Figure 26. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application in 2019 Figure 27. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2015-2020) Figure 28. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application in 2019 Figure 29. North America Alpha-1 Antitrypsin Drugs Sales Growth Rate 2015-2020 (K Units) Figure 30. North America Alpha-1 Antitrypsin Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 31. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Country in 2019 Figure 32. North America Alpha-1 Antitrypsin Drugs Revenue Market Share by Country in 2019 Figure 33. U.S. Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 34. U.S. Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Canada Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 36. Canada Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. North America Alpha-1 Antitrypsin Drugs Market Share by Type in 2019 Figure 38. North America Alpha-1 Antitrypsin Drugs Market Share by Application in 2019 Figure 39. Europe Alpha-1 Antitrypsin Drugs Sales Growth Rate 2015-2020 (K Units) Figure 40. Europe Alpha-1 Antitrypsin Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 41. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Country in 2019 Figure 42. Europe Alpha-1 Antitrypsin Drugs Revenue Market Share by Country in 2019 Figure 43. Germany Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 44. Germany Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. France Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 46. France Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. U.K. Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 48. U.K. Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Italy Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 50. Italy Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Russia Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 52. Russia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Europe Alpha-1 Antitrypsin Drugs Market Share by Type in 2019 Figure 54. Europe Alpha-1 Antitrypsin Drugs Market Share by Application in 2019 Figure 55. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Growth Rate 2015-2020 (K Units) Figure 56. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 57. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Market Share by Region in 2019 Figure 58. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue Market Share by Region in 2019 Figure 59. China Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 60. China Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Japan Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 62. Japan Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. South Korea Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 64. South Korea Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. India Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 66. India Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Australia Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 68. Australia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Taiwan Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 70. Taiwan Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Indonesia Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 72. Indonesia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Thailand Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 74. Thailand Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Malaysia Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 76. Malaysia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Philippines Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 78. Philippines Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Vietnam Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 80. Vietnam Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Asia Pacific Alpha-1 Antitrypsin Drugs Market Share by Type in 2019 Figure 82. Asia Pacific Alpha-1 Antitrypsin Drugs Market Share by Application in 2019 Figure 83. Latin America Alpha-1 Antitrypsin Drugs Sales Growth Rate 2015-2020 (K Units) Figure 84. Latin America Alpha-1 Antitrypsin Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 85. Latin America Alpha-1 Antitrypsin Drugs Sales Market Share by Country in 2019 Figure 86. Latin America Alpha-1 Antitrypsin Drugs Revenue Market Share by Country in 2019 Figure 87. Mexico Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 88. Mexico Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 89. Brazil Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 90. Brazil Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 91. Argentina Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 92. Argentina Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 93. Latin America Alpha-1 Antitrypsin Drugs Market Share by Type in 2019 Figure 94. Latin America Alpha-1 Antitrypsin Drugs Market Share by Application in 2019 Figure 95. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Growth Rate 2015-2020 (K Units) Figure 96. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 97. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Country in 2019 Figure 98. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue Market Share by Country in 2019 Figure 99. Turkey Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 100. Turkey Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 101. Saudi Arabia Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 102. Saudi Arabia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 103. U.A.E Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units) Figure 104. U.A.E Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 105. Middle East and Africa Alpha-1 Antitrypsin Drugs Market Share by Type in 2019 Figure 106. Middle East and Africa Alpha-1 Antitrypsin Drugs Market Share by Application in 2019 Figure 107. North America Alpha-1 Antitrypsin Drugs Sales Growth Rate Forecast (2021-2026) (K Units) Figure 108. North America Alpha-1 Antitrypsin Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 109. Europe Alpha-1 Antitrypsin Drugs Sales Growth Rate Forecast (2021-2026) (K Units) Figure 110. Europe Alpha-1 Antitrypsin Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 111. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Growth Rate Forecast (2021-2026) (K Units) Figure 112. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 113. Latin America Alpha-1 Antitrypsin Drugs Sales Growth Rate Forecast (2021-2026) (K Units) Figure 114. Latin America Alpha-1 Antitrypsin Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 115. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Growth Rate Forecast (2021-2026) (K Units) Figure 116. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 117. Porter's Five Forces Analysis Figure 118. Channels of Distribution Figure 119. Distributors Profiles Figure 120. Bottom-up and Top-down Approaches for This Report Figure 121. Data Triangulation Figure 122. Key Executives Interviewed

Get Free Sample

Related Reports

Global Alpha-1 Antitrypsin Drugs Market Insights and Forecast to 2026

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Global Alpha-1 Antitrypsin Drugs Market Insights and Forecast to 2026

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Global Alpha-1 Antitrypsin Drugs Market Insights and Forecast to 2026

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Global Alpha-1 Antitrypsin Drugs Market Insights and Forecast to 2026

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Global Alpha-1 Antitrypsin Drugs Market Insights and Forecast to 2026

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)